Impacts of British Columbia's free contraception policy on out-of-pocket payments and contraception costs: an interrupted time series analysis with other provinces as controls
Nethery, E.; Law, M. R.; Chang, L.; Bryan, S.; Clement, F.; Nickel, N.; Norman, W. V.; Black, A.; Helmer-Smith, M.; McGrail, K. M.; Schummers, L.
Show abstract
BackgroundCost is a key driver of inadequate, unequal contraception access. Without a national public pharmacare plan, Canadians use a mix of private or public prescription insurance plans to pay for drugs or devices. High deductibles, copayments, and/or exclusion of contraception from insurance formularies can result in access gaps. In April 2023, the western-most Canadian province (British Columbia (BC)) introduced universal, first-dollar coverage for prescription contraception. We estimated the effect of this free contraception policy on prescription contraception payer type and costs. MethodsUsing a national prescription database, we measured the monthly proportion of all dispensed contraception to reproductive-aged females (15-49y) in BC according to majority payer (out-of-pocket (patients), private, and public) and estimated costs per capita by payer type. We used a controlled interrupted time series analysis to compare outcomes in BC to expected trends if the policy had not been introduced and compared with synthetic controls derived from other Canadian provinces. FindingsPre-policy in BC, 39% of prescription contraception was paid out-of-pocket, 49% by private insurance, and 12% by public insurance. When BCs policy was introduced, out-of-pocket payments immediately decreased (-24.3% 95%CI -24.8 to -23.7). At 2-years post-policy, 5.4% (95% CI 4.5% to 6.4%) of on-formulary contraceptives were paid out-of-pocket and 8.4% (7.5% to 9.3%) was paid by private insurance. Total monthly per capita out-of-pocket costs in BC were 86% lower than expected if the policy had not been implemented. Time trends pre-and post-policy were similar in BC and controls. InterpretationUp to 40% of contraceptives were previously paid out-of-pocket in BC compared to prior studies showing 20% of all drugs in Canada were paid out-of-pocket. Contraception may be uniquely sensitive to inadequate insurance coverage as with a mix of public and private drug plans. The implementation of a public drug plan providing universal, first-dollar coverage policy for contraception substantially reduced out-of-pocket payments for dispensed contraception. Key pointsO_LIBefore policy implementation, 40% of contraception prescriptions in BC were paid out-of-pocket - double the national average for all prescription drugs - highlighting major gaps in coverage and inequitable access to contraception. C_LIO_LIA universal, first-dollar contraception policy reduced out-of-pocket costs by 86% within two years, with only 5% of on-formulary contraceptive prescriptions still paid out-of-pocket C_LIO_LIFirst-dollar public coverage effectively removes financial barriers and supports equitable access to contraception, providing timely evidence to inform national pharmacare implementation. C_LI
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- How do perceptions of Covid-19 risk impact pregnancy-related health decisions? A convergent parallel mixed-methods study protocol 91%
- Measurement of changes to the menstrual cycle: A transdisciplinary systematic review evaluating measure quality and utility for clinical trials 90%
- The aggregate effect of implementation strength of family planning programs on modern contraceptive use at the health systems level in rural Malawi 90%
Similar papers in this journal
- Effect of the Friendship Bench intervention on antiretroviral therapy outcomes and mental health symptoms in rural Zimbabwe: A cluster randomized trial 90%
- Regional Variation in Antenatal Late Preterm Steroid Use following the ALPS Trial 90%
- Public Preferences for Social Distancing Behaviors to Mitigate the Spread of COVID-19: A Discrete Choice Experiment 89%
Similar papers in this journal
- Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe 90%
- COVID-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021-2022: a repeated cross-sectional study 89%
- Factors associated with contraceptive use among reproductive-age women during a pandemic: Evidence from a small developing state 89%
Similar papers in this journal
- Widely accessible prognostication using medical history for fetal growth restriction and small for gestational age in nationwide insured women 90%
- Sociodemographic Characteristics of Missing Data in Digital Phenotyping 89%
- SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology 88%
Similar papers in this journal
- Positive deviance for promoting dual-method contraceptive use among women in Uganda: a cluster randomized controlled trial 92%
- Improving experience of medical abortion at home in a changing therapeutic, technological and regulatory landscape: a realist review 91%
- Landscape Analysis of Pregnancy Exposure Registries in Low- and Middle-Income Countries: a Scoping Review 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.